- What are
- Partner Identification Services?
DelveInsight’s partnering services provide opportunities to collaborate on a project where a company’s interest lies. Through extensive networks and detailed partnering methodology, our team is uniquely positioned to create a value-based relationship for our clients. The service platform scouts perfect candidates for partnership through a meticulous examination of unmet needs, validation of scientific and business perspectives, and strategic fit.
Our Partnership Methodology Involves:
- Descriptive definition of the arena of interest to track intelligence leads
- Assessment of assets and technologies through defined landscaping parameters
- A transparent process updates for real-time understanding of the progress
- Test and re-test partnering hypothesis through in-house analysis tools
- Assigning different levels of interest to potential leads for stratified engagement
- Discernment of other party’s interest in the partnership proposal
Fostering long-term relationships among Pharmaceutical/Biotech companies provides an incentive to both partners, creating value for all the stakeholders involved. Here, companies might know what they want, but to go about the process is another ball game altogether.
- Identifying, monitoring, and evaluating organizational barriers are judicial for maintaining a strong foothold in the market
- Prioritizing interest provides an inherent challenge of finding another company of similar interests
- The different degrees of priorities while conducting potential engagement might not produce the required results if the scouting isn’t done correctly.
Source: - Delve Partners
2. What are Pharmaceutical Portfolio Management Solutions?
DelveInsight’s Portfolio Management services provide unmatched assistance in understanding your competencies, leverage strengths to prioritize strategic goals, understand the current needs of the market and likewise work on creating value for the customers, as well as for the company.
Our Portfolio Management Methodology Provides:
- Define goals of the company to segregate priorities
- List probable avenues of Organizational Success
- Assess Potential Changes in the Industry
- Understanding the needs of the End-user
- Channelize strengths to improve strategy
- Implement resource and cost-saving processes
Shrinking pipelines, lack of innovative ideas, increased cost of therapy development, regulatory pressures, reimbursement issues, and stagnation in revenue through previous innovative therapy sales- these are some of the major issues plaguing the Pharma sector and are also reasons which are forcing these companies to rethink their clinical developmental strategy to meet corporate goals.
- There is an issue in not being able to understand which areas of focus might or might not align with the vision of the company, depleting valuable resources of the company that could otherwise be utilized on something that may prove to be beneficial in the future.
- A major aspect to be considered here is to understand one’s core competencies, assess the assets and products that can be managed with those core competencies, and then understand the bounds of one’s developmental and commercial aspects.
- Portfolio management not only includes the assessment of products whose development might be beneficial for the company’s future growth but also aligns the competencies of the company with the vision of the company, creating a positive organizational culture and potent workforce.
Source: - Portfolio Manager Pharma
